Medication info

Wivix Tablet

Prescription medicationApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›Strength being verifiedTripotassium Bismuth Dicitrate›Strength being verifiedSucralfate Hydrate›Strength being verified
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201903225 · Approved 2019.05.20

This product's status changed to Approval withdrawn on 2023.06.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers and gastritis) and Zollinger-Ellison syndrome; prevention of Mendelson's syndrome
Who uses it
Adults
Adult dosage
Usually, irrespective of meals, take 2 tablets per dose twice daily, in the morning and before bedtime. 1) Gastric and duodenal ulcers Take 2 tablets per dose twice daily, or 4 tablets once daily before bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 4 tablets per dose twice daily, in the morning and before bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and for concomitant use to prevent gastric and duodenal ulcers during long-term NSAID treatment. Conditions caused by NSAID use usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets per dose twice daily, or 4 tablets once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose if necessary. In severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Give 2 tablets as a single dose 2 hours before induction of anesthesia. In this case, it is preferable to also give 2 tablets as a single dose on the night before surgery.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers and gastritis) and Zollinger-Ellison syndrome; prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers due to non-steroidal anti-inflammatory drugs (NSAIDs)
View approved original text

This medication is used to treat gastrointestinal issues such as ulcers in the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. Additionally, it helps prevent Mendelson's syndrome during pre-operative anesthesia and aids in treating ulcers that may arise post-surgery. It is also effective in treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This medication reduces gastric acid secretion, protecting the mucosa of the digestive system, and helps alleviate symptoms and promote healing. Overall, it is used to improve and treat symptoms related to gastrointestinal disorders.

Dosage and Administration

Adult dosage

Usually, irrespective of meals, take 2 tablets per dose twice daily, in the morning and before bedtime. 1) Gastric and duodenal ulcers Take 2 tablets per dose twice daily, or 4 tablets once daily before bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 4 tablets per dose twice daily, in the morning and before bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and for concomitant use to prevent gastric and duodenal ulcers during long-term NSAID treatment. Conditions caused by NSAID use usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily before bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets per dose twice daily, or 4 tablets once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose if necessary. In severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Give 2 tablets as a single dose 2 hours before induction of anesthesia. In this case, it is preferable to also give 2 tablets as a single dose on the night before surgery.

Precautions

This medication should not be used by patients undergoing dialysis. Patients with a history of allergic reactions to this medication or its components should also avoid use. It is not recommended for patients with the rare disease acute porphyria, as it may induce seizures. It is also safer not to administer this medication to patients with impaired kidney function. Patients who have undergone gastric surgery should not use this medication. It is advisable for women who are pregnant or may become pregnant to avoid taking this medication. Its safety has not been established for infants or newborns. Patients on a potassium-restricted diet should also refrain from using this medication. Patients with liver function issues or a history of drug allergies should use this medication with caution. Elderly patients or those who have had past kidney problems should also use with care. If combined with non-steroidal anti-inflammatory drugs, regular monitoring of gastric health is necessary. This medication may mask symptoms of gastric cancer, therefore patients with gastric ulcers or indigestion over the age of middle age should verify the presence of malignancy before administration. Patients with gastric or duodenal ulcers caused by Helicobacter pylori require treatment to eradicate the bacteria. In critically ill patients in the intensive care unit, caution is needed as it may lead to gastrolithiasis. Patients with hypophosphatemia may experience interference with phosphate absorption due to the aluminum content of this medication. Patients with dysphagia may face respiratory complications after taking this medication, thus caution is needed. While taking this medication, rare allergic reactions or shock may occur, so if symptoms arise, stop taking it immediately and inform medical personnel. There may be a decrease in blood cell count or liver function anomalies, so patients should undergo tests if they notice abnormal symptoms. Symptoms like irregular heartbeat, digestive disorders, dizziness, drowsiness, and mental confusion should be observed carefully. Rarely, muscle pain or joint pain may also occur, and treatment should be ceased if abnormalities appear. Skin-related symptoms like rashes or alopecia have also been reported. Long-term use is not recommended, and during treatment, symptoms and test results should be checked periodically. Elderly patients, those with chronic lung diseases, diabetes, or weakened immune systems may have an increased risk of pneumonia, requiring caution. If dizziness or drowsiness occurs after taking this medication, individuals should avoid driving or operating dangerous machinery. There may be interactions with other medications, so especially if taking anticoagulants or specific antibiotics or anticonvulsants, it is necessary to consult with a physician or pharmacist. There may be effects on the absorption or excretion of other drugs taken concurrently, so adjusting the timing of administration may be necessary. It is safer for women who are pregnant or breastfeeding to avoid this medication. Safety for children has not been established, so it is advisable not to use.

Side effects

  • anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 48 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous and submucosal hemorrhage
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • excitement
  • insomnia
  • headache
  • heaviness in the head
  • illness perception
  • anxiety
  • delirium
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorder
  • consciousness disorder
  • tonic-clonic muscle spasms
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure and is best kept at room temperature between 1 degree Celsius and 30 degrees Celsius. This way, the medication's effectiveness can be maintained for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.